Online citations, reference lists, and bibliographies.
← Back to Search

Epidemiology: Extent Of The Problem

S. Sibio, Joseph Maher Fouad Atta, Alessio Impagnatiello, B. Sollazzo, D. Marrelli
Published 2015 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Peritoneal carcinomatosis (PC) most commonly represents local or regional evolution of an abdominal carcinoma. Sometimes it can be synchronous with the primary tumor (primary carcinomatosis) but more often is present as recurrent disease (metachronous or secondary) after first-line treatment of the originating tumor. Patients with tumors from colon, ovary, and stomach cancer are more likely to present with PC during their clinical course. Less frequently, other abdominal malignancies, such as uterus, pancreas, small bowel, biliary, or urinary tract, can involve the peritoneum. Tumors originating from the peritoneum itself are definitely rarer: mesothelioma, pseudomyxoma peritonei (PMP), primitive peritoneal carcinoma, and desmoplastic small-round-cell tumor. PC from extra-abdominal tumors, such as lung, breast, melanoma, or peritoneal sarcomatosis, is exceptional, and few epidemiological data are available on them. Statistical analysis of worldwide cancer incidence, prevalence, and mortality rate is available on GLOBOCAN 2012 [1]. In Italy, most epidemiological data are available in the reports from the Italian Association of Tumor Registries (AIRTUM) [2], which collects data regarding incidence, prevalence, and mortality rates from all local and regional tumor registries, covering at least 34% of total population. This data is considered a high-quality regional coverage by and international ranking system (GLOBOCAN 2012 rate B).
This paper references
10.1097/MPA.0b013e31825abf8c
Incidence, Prognosis, and Possible Treatment Strategies of Peritoneal Carcinomatosis of Pancreatic Origin: A Population-Based Study
I. Thomassen (2013)
10.1016/J.EJSO.2007.04.002
Appendiceal neoplasms and pseudomyxoma peritonei: a population based study.
R. M. Smeenk (2008)
10.1016/0002-9610(83)90207-6
Second laparotomy for proximal colon cancer. Sites of recurrence and implications for adjuvant therapy.
D. Tong (1983)
10.3322/canjclin.55.2.74
Global Cancer Statistics, 2002
D. Parkin (2005)
10.1097/DCR.0b013e3182a62d9d
Incidence, Prognosis, and Treatment Options for Patients With Synchronous Peritoneal Carcinomatosis and Liver Metastases from Colorectal Origin
I. Thomassen (2013)
10.1002/1097-0142(19840115)53:2<360::AID-CNCR2820530232>3.0.CO;2-U
Adenocarcinoma of the proximal colon sites of initial dissemination and patterns of recurrence following surgery alone
A. Russell (1984)
10.1002/1097-0142(19820315)49:6<1131::AID-CNCR2820490611>3.0.CO;2-T
Carcinoma of the colon and rectum: The natural history reviewed in 1704 patients
B. Eisenberg (1982)
10.1159/000052897
Pseudomyxoma Peritonei: A Review of Current Literature
D. Sherer (2001)
10.1046/J.1365-2168.2002.02274.X
Peritoneal carcinomatosis from colorectal cancer
D. Jayne (2002)
10.1016/j.ygyno.2013.12.017
High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease.
R. Bristow (2014)
10.1097/01.sla.0000197702.46394.16
Peritoneal Carcinomatosis of Colorectal Origin: Incidence and Current Treatment Strategies
M. Koppe (2006)
10.3892/ol.2013.1468
Lung cancer and peritoneal carcinomatosis
M. Sereno (2013)
10.1186/1471-2407-14-148
Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab
D. Goéré (2013)
10.1002/jso.21619
Cytoreductive surgery and hyperthermic intra‐peritoneal chemotherapy (HIPEC) for gastric adenocarcinoma: Why haven't we reached the promised land?
A. Nissan (2010)
10.1016/j.ejca.2009.04.027
Peritoneal disease in breast cancer: a specific entity with an extremely poor prognosis.
M. Tuthill (2009)
10.1016/0360-3016(85)90305-0
Extrapelvic colon--areas of failure in a reoperation series: implications for adjuvant therapy.
L. Gunderson (1985)
10.1007/s00268-010-0396-5
Predictive Factors Improving Survival After Gastrectomy in Gastric Cancer Patients with Peritoneal Carcinomatosis
Masayoshi Hioki (2010)
10.1093/JNCI/DJG040
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.
H. Weir (2003)
10.1002/bjs.7528
Changing clinical and pathological features of gastric cancer over time
D. Marrelli (2011)
10.1016/S0140-6736(95)90462-X
Continuing increase in mesothelioma mortality in Britain
J. Peto (1995)
10.1002/BJS.1800710311
Sites of recurrent tumour after ‘curative’ colorectal surgery: Implications for adjuvant therapy
J. Gilbert (1984)
10.1002/1097-0142(197606)37:6<2861::AID-CNCR2820370643>3.0.CO;2-3
Patterns of recurrence following surgery alone for adenocarcinoma of the colon and rectum
A. Cass (1976)
10.1002/1097-0142(19850915)56:6<1446::AID-CNCR2820560636>3.0.CO;2-5
Adenocarcinoma of the colon: An autopsy study with implications for new therapeutic strategies
A. Russell (1985)
10.1016/J.HUMPATH.2005.06.006
Hereditary ovarian cancer.
J. Prat (2005)
10.1002/1097-0142(19880401)61:7<1408::AID-CNCR2820610722>3.0.CO;2-A
Resectable adenocarcinoma of the rectosigmoid and rectum. I. Patterns of failure and survival
B. Minsky (1988)
10.1002/1097-0142(19800615)45:12<2969::AID-CNCR2820451214>3.0.CO;2-7
Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum
R. M. Olson (1980)
10.1016/0360-3016(83)90384-X
PATTERNS OF RECURRENCE IN ADENOCARCINOMA OF THE RECTUM AND RECTOSIGMOID TREATED WITH SURGERY ALONE: IMPLICATIONS IN TREATMENT PLANNING WITH ADJUVANT RADIATION THERAPY
W. Mendenhall (1983)
10.3322/caac.20107
Global cancer statistics
A. Jemal (2011)
10.1007/s10552-014-0357-7
The association between neighborhood socioeconomic status and ovarian cancer tumor characteristics
C. Peterson (2014)
Analysis of recurrence patterns following curative resection for carcinoma of the colon and rectum.
Arnold W. Malcolm (1981)
10.1016/j.ejso.2012.07.009
Outcome differences between debulking surgery and cytoreductive surgery in patients with Pseudomyxoma peritonei.
H. Andréasson (2012)
10.1093/ANNONC/MDL345
Epidemiology of peritoneal mesothelioma: a review.
P. Boffetta (2007)
10.1016/0360-3016(82)90377-7
Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy.
L. Gunderson (1982)
10.1002/bjs.4164
Prospective study of peritoneal recurrence after curative surgery for gastric cancer
F. Roviello (2003)
European Union Network of Excellence (EUNE) for Gastric Cancer Steering Group
W. Allum (2008)
10.1002/ijc.23874
Survival of pleural malignant mesothelioma in Italy: A population‐based study
F. Montanaro (2009)



Semantic Scholar Logo Some data provided by SemanticScholar